http://europebusines.blogspot.com/200 ... armageddon-has-begun.html

Vad fan är detta?
Det finns bara två svar. Antingen så har infokriget eskalerat eller så har kriget mot mänskligheten intensifierats.

Ser ni några andra svar? Skitsnack eller tråkiga nyheter?

Så här skriver Ken Welch på sin sida och jag läste det första gången gör kanske 1-1½ månad sen.

You will be told that swine flu has made it into bird populations and magically mutated to create a deadly, rapidly spreading form of Bird Flu. There will be no truth to this at all. The virus they will release is the recreated 1918 virus, already in many bio labs, and perhaps boosted a bit from the original 1918 variety in terms of lethality. You are being given a psychological practice run for this scenario right now, with scary but exaggerated stories from Ukraine.

The world will be told that there are no vaccines that can touch it. It will spread slowly at first, but by mid January it will be sweeping the globe. Make no mistake. This is the one I’ve been warning about, and you will literally see bodies on the sidewalk if the records from 1918 are to be believed.

Jag grävde i det lite och kom inte ihåg hur jag gled in på botemedel.
Vi sötte på nånting som kallas OX40-ig. Råder er och kolla upp denna produkt och hjälpa till med detta. Spåren ledde oss till Celtic Pharma som köpte upp OX40-ig.

[url=http://www.celticpharma.com/news/index.html]
Till höger i listan på den enda du inte kan klicka dit kom jag. sen tog spåren slut.
• Xenova acquisition completed

OX40-ig verkar vara vår räddning dold för oss.

Lyfter denna

OX40 IG

A 2003 report in the Journal of Experimental Medicine published by researchers at Imperial College London demonstrates[10] the possibility of preventing a cytokine storm by inhibiting or disabling T-cell response. A few days after T cells are activated, they produce a biologic molecule called OX40, a "survival signal" that keeps activated T-cells working at the site of inflammation during infection with influenza or other pathogens. OX40 binds to receptors on T-cells, preventing them from dying and subsequently increasing cytokine production. A combined protein, OX40-immunoglobulin (OX40-Ig), a human-made fusion protein, prevents OX40 from reaching the T-cell receptors, thus reducing the T-cell response. Experiments in mice have demonstrated that OX40-Ig can reduce the symptoms associated with an immune overreaction while allowing the immune system to fight off the virus successfully. By blocking the OX40 receptor on T-cells, researchers were able to prevent the development of the most serious flu symptoms in these experimental mice[10] and reported the results in New Scientist.[11] The drug, to be made by a company called Xenova Research (Xenova Research was purchased by Celtic Pharma, a private equity firm, in September 2005), was supposed to be in phase I clinical trial in 2004, but its status is currently unknown.[12]

In addition, preliminary data has shown that simvastatin induced down-regulation of OX40 and OX40L mRNA and protein in a concentration-dependent manner, and antagonized the interferon-gamma-induced increase in OX40 and OX40L mRNA and protein levels. Further, serum levels of soluble OX40L and matrix metalloproteinase 9 levels were significantly reduced in patients with atherosclerotic cerebral infarction who were treated for 6 months with routine therapy plus simvastatin (n = 46) compared with patients receiving routine therapy alone (n = 30).[1